The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
The toxicological mode of action and the safety of synthetic amorphous silica—A nanostructured material
Open accessAbstract
Synthetic amorphous silica (SAS), in the form of pyrogenic (fumed), precipitated, gel or colloidal SAS, has been used in a wide variety of industrial and consumer applications including food, cosmetics and pharmaceutical products for many decades. Based on extensive physico-chemical, ecotoxicology, toxicology, safety and epidemiology data, no environmental or health risks have been associated with these materials if produced and used under current hygiene standards and use recommendations. With internal structures in the nanoscale size range, pyrogenic, precipitated and gel SAS are typical examples of nanostructured materials as recently defined by the International Organisation for Standardisation (ISO). The manufacturing process of these SAS materials leads to aggregates of strongly (covalently) bonded or fused primary particles. Weak interaction forces (van der Waals interactions, hydrogen bonding, physical adhesion) between aggregates lead to the formation of micrometre (μm)-sized agglomerates. Typically, isolated nanoparticles do not occur. In contrast, colloidal SAS dispersions may contain isolated primary particles in the nano-size range which can be considered nano-objects. The size of the primary particle resulted in the materials often being considered as "nanosilica" and in the inclusion of SAS in research programmes on nanomaterials. The biological activity of SAS can be related to the particle shape and surface characteristics interfacing with the biological milieu rather than to particle size. SAS adsorbs to cellular surfaces and can affect membrane structures and integrity. Toxicity is linked to mechanisms of interactions with outer and inner cell membranes, signalling responses, and vesicle trafficking pathways. Interaction with membranes may induce the release of endosomal substances, reactive oxygen species, cytokines and chemokines and thus induce inflammatory responses. None of the SAS forms, including colloidal nano-sized particles, were shown to bioaccumulate and all disappear within a short time from living organisms by physiological excretion mechanisms with some indications that the smaller the particle size, the faster the clearance is. Therefore, despite the new nomenclature designating SAS a nanomaterial, none of the recent available data gives any evidence for a novel, hitherto unknown mechanism of toxicity that may raise concerns with regard to human health or environmental risks. Taken together, commercial SAS forms (including colloidal silicon dioxide and surface-treated SAS) are not new nanomaterials with unknown properties, but are well-studied materials that have been in use for decades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlled growth of monodisperse silica spheres in the micron size range
Stöber, W., Fink, A., & Bohn, E. (1968) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(68)90272-5 · Cited by 14,532
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
US Environmental Protection Agency
(1998) · Choice Reviews Online · doi:10.5860/choice.35-4455 · Cited by 5,897
Occurrence, behavior and effects of nanoparticles in the environment
Nowack, B., & Bucheli, T. D. (2007) · Environmental Pollution · doi:10.1016/j.envpol.2007.06.006 · Cited by 2,286
Comparative eco-toxicity of nanoscale TiO2, SiO2, and ZnO water suspensions
Adams, L. K., Lyon, D. Y., & Alvarez, P. J. J. (2006) · Water Research · doi:10.1016/j.watres.2006.08.004 · Cited by 1,543
Lehrbuch der Anorganischen Chemie
Holleman, A. F., und Nils Wiberg, E., & Fischer, G. (2007) · De Gruyter eBooks · doi:10.1515/9783110177701 · Cited by 1,446
Organisation for Economic Co-Operation and Development
(2016) · The SAGE Encyclopedia of Pharmacology and Society · doi:10.4135/9781483349985.n291 · Cited by 1,391
Brunner, T. J., Wick, P., Manser, P., Spohn, P., Grass, R. N., Limbach, L. K., Bruinink, A., & Stark, W. J. (2006) · Environmental Science & Technology · doi:10.1021/es052069i · Cited by 1,385
The potential risks of nanomaterials: a review carried out for ECETOC.
Borm, P. J. A., Robbins, D. J., Haubold, S., Kuhlbusch, T. A. J., Fissan, H. J., Donaldson, K., Schins, R. P. F., Stone, V., Kreyling, W. G., Lademann, J. M., et al. (2006) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-3-11 · Cited by 1,379
Cited by
Mesoporous silica nanoparticles in target drug delivery system: A review
Bharti, C., Gulati, N., Nagaich, U., & Pal, A. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.160844 · Cited by 817
Micro- and Nano-plastics and Human Health
Galloway, T. S. (2015) · Marine Anthropogenic Litter · doi:10.1007/978-3-319-16510-3_13 · Cited by 527
Toxicology of silica nanoparticles: an update
Murugadoss, S., Lison, D., Godderis, L., Van Den Brule, S., Mast, J., Brassinne, F., Sebaihi, N., & Hoet, P. H. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1993-y · Cited by 518
Nonporous silica nanoparticles for nanomedicine application
Tang, L., & Cheng, J. (2013) · Nano Today · doi:10.1016/j.nantod.2013.04.007 · Cited by 488
Comparative assessment of nanomaterial definitions and safety evaluation considerations
Boverhof, D. R., Bramante, C. M., Butala, J. H., Clancy, S. F., Lafranconi, M., West, J., & Gordon, S. C. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.06.001 · Cited by 443
EFSA Scientific Committee, Hardy, A., Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., Noteborn, H., Ockleford, C., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5327 · Cited by 416
EFSA Scientific Committee, More, S., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T., Hernández‐Jerez, A., Hougaard Bennekou, S., Koutsoumanis, K., Lambré, C., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6768 · Cited by 395
Interactions between Metal Oxides and Biomolecules: from Fundamental Understanding to Applications
Limo, M. J., Sola-Rabada, A., Boix, E., Thota, V., Westcott, Z. C., Puddu, V., & Perry, C. C. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00660 · Cited by 287
Recent applications of immunomodulatory biomaterials for disease immunotherapy
Dai, H., Fan, Q., & Wang, C. (2022) · Exploration · doi:10.1002/exp.20210157 · Cited by 268
A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)
Arts, J. H. E., Hadi, M., Irfan, M.-A., Keene, A. M., Kreiling, R., Lyon, D., Maier, M., Michel, K., Petry, T., Sauer, U. G., et al. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.03.007 · Cited by 256
Removal of chromium from industrial effluents using nanotechnology: A review
Mitra, S., Sarkar, A., & Sen, S. (2017) · Nanotechnology for Environmental Engineering · doi:10.1007/s41204-017-0022-y · Cited by 151
Characteristics of nano-plastics in bottled drinking water
Huang, Y., Wong, K. K., Li, W., Zhao, H., Wang, T., Stanescu, S., Boult, S., van Dongen, B., Mativenga, P., & Li, L. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127404 · Cited by 84
From Dose to Response: In Vivo Nanoparticle Processing and Potential Toxicity
Graham, U. M., Jacobs, G., Yokel, R. A., Davis, B. H., Dozier, A. K., Birch, M. E., Tseng, M. T., Oberdörster, G., Elder, A., & DeLouise, L. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47754-1_4 · Cited by 59
Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook
Singh, N., Shi, S., & Goel, S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114638 · Cited by 35
Metadata
- Authors
- Fruijtier-Pölloth, C.
- Venue
- Toxicology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 294
- Issue
- 2-3
- Pages
- 61-79
- ISSN
- 0300-483X (ISSN-L)
- OpenAlex
- W2051127799
- Cited by
- 312
- References
- 99
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.